KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Globus Medical (GMED) Depreciation & Amortization - Total (2024 - 2025)

Globus Medical's Depreciation & Amortization - Total history spans 2 years, with the latest figure at $30.1 million for Q3 2025.

  • For Q3 2025, Depreciation & Amortization - Total rose 7.1% year-over-year to $30.1 million; the TTM value through Dec 2025 reached $88.7 million, down 12.1%, while the annual FY2024 figure was $100.9 million, 40.66% up from the prior year.
  • Depreciation & Amortization - Total reached $30.1 million in Q3 2025 per GMED's latest filing, up from $29.6 million in the prior quarter.
  • In the past five years, Depreciation & Amortization - Total ranged from a high of $30.1 million in Q3 2025 to a low of $17.3 million in Q1 2024.